Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Insolvency Petition

Shilpa Medicare Insolvency Petition

Shilpa Medicare reports NCLAT set aside the CIRP against its subsidiary FTF Pharma, annulling the process. The filing states no impact on the listed entity.

Source

BSE filing, NSE: SHILPAMED. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Shilpa Medicare Ltd: key numbers

Share price
₹923.00
Market cap
₹18,052 Cr
Revenue (annual)
₹1,539 Cr
Net profit (annual)
₹243.3 Cr
P/E (TTM)
54.3×Sector 37.9×
Promoter holding
40.13%+0.00% QoQ
FII holding
12.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shilpa Medicare Ltd

All →

Other insolvency petition announcements

All →